Oncology CAR-TCR 2023 – Mindy Miller As more cell therapies are approved and the category emerges, there’s also an increased need for the technology that enables cell therapy development.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.